{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:01:42Z","timestamp":1782284502699,"version":"3.54.5"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Symptomatic neuroma is a debilitating complication of peripheral nerve injury. Techniques like targeted muscle reinnervation and regenerative peripheral nerve interfaces have shown promise but have critical limitations, including inconsistent efficacy, increased operative time and morbidity, and the need for microsurgical training specific to peripheral nerves. We present the first clinical experience with a sutureless, bioresorbable hydrogel (allay Nerve Cap) for the treatment and prevention of symptomatic neuroma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A single-center retrospective review of 11 patients who underwent 12 nerve procedures (23 nerves) involving hydrogel nerve cap placement was conducted. Ten of the 12 procedures were prophylactic, and 2 were for established diagnosis of symptomatic neuroma. In the symptomatic neuroma group, pre- and postoperative visual analog scale scores were obtained. All patients had a minimum 6 months of follow-up and were monitored for the development of neuropathic symptoms. The time required for intraoperative nerve hydrogel application was recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>No patients in the prophylactic group developed symptomatic neuromas or neuropathic symptoms postoperatively. Both patients with established symptomatic neuroma experienced a significant decrease in visual analog scale score (4 and 7 points, respectively). There were no hydrogel-related complications. Minor wound issues occurred in 3 patients, and 1 patient died approximately 6 months postoperatively due to her underlying medical condition. The duration of hydrogel application averaged 55 seconds per nerve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Early experience with the hydrogel cap suggests it is a safe, effective, and scalable device for prevention and treatment of symptomatic neuroma across a broad range of procedures and anatomical locations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/gox.0000000000007339","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:00:48Z","timestamp":1765803648000},"page":"e7339","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A Novel Hydrogel for Treatment and Prevention of Symptomatic Neuroma: Early Clinical Experience"],"prefix":"10.1097","volume":"13","author":[{"given":"Patryk","family":"Ostrowski","sequence":"first","affiliation":[{"name":"Jagiellonian University Medical College, Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Deng","sequence":"additional","affiliation":[{"name":"Bernard J. Tyson School of Medicine, Pasadena, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Kobraei","sequence":"additional","affiliation":[{"name":"ART Microsurgery and Nerve Center, Kaiser Permanente San Jose Medical Center, San Jose, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SAP.0000000000001796","article-title":"Diagnostic criteria for symptomatic neuroma.","volume":"82","author":"Arnold","year":"2019","journal-title":"Ann Plast Surg"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.bjps.2013.06.019","article-title":"The incidence of symptomatic neuroma in amputation and neurorrhaphy patients.","volume":"66","author":"van der Avoort","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"86.e1","DOI":"10.1016\/j.jhsa.2017.08.021","article-title":"Symptomatic neuroma following initial amputation for traumatic digital amputation.","volume":"43","author":"Vlot","year":"2018","journal-title":"J Hand Surg Am"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00005373-198302000-00012","article-title":"Neuroma formation following digital amputations.","volume":"23","author":"Fisher","year":"1983","journal-title":"J Trauma"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0266-7681(85)80013-9","article-title":"Results of digital neurorrhaphy in adults.","volume":"10","author":"Sullivan","year":"1985","journal-title":"J Hand Surg Br"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-4804(77)90024-5","article-title":"The painful neuroma: the regenerating axon versus the epineural sheath.","volume":"23","author":"Nelson","year":"1977","journal-title":"J Surg Res"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/PRS.0000000000005664","article-title":"Surgery for symptomatic neuroma: anatomic distribution and predictors of secondary surgery.","volume":"143","author":"Wolvetang","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1213\/ANE.0b013e31824f94ca","article-title":"The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.","volume":"115","author":"Miyazaki","year":"2012","journal-title":"Anesth Analg"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"e1952","DOI":"10.1097\/GOX.0000000000001952","article-title":"Surgical algorithm for neuroma management: a changing treatment paradigm.","volume":"6","author":"Eberlin","year":"2018","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0007-1226(90)90057-7","article-title":"Intractable digital neuroma pain: the ultimate solution?","volume":"43","author":"Kumar","year":"1990","journal-title":"Br J Plast Surg"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0007-1226(97)91367-9","article-title":"Prevention of painful neuromas by epineural ligatures, flaps and grafts.","volume":"50","author":"Y\u00fcksel","year":"1997","journal-title":"Br J Plast Surg"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00006534-198603000-00016","article-title":"Treatment of the painful neuroma by neuroma resection and muscle implantation.","volume":"77","author":"Dellon","year":"1986","journal-title":"Plast Reconstr Surg"},{"key":"R13-20251215","first-page":"e39567","article-title":"Neuroma treatment with the acellular nerve allograft reconstruction technique.","volume":"15","author":"Bell","year":"2023","journal-title":"Cureus"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/SAP.0000000000003596","article-title":"Surgical treatment of symptomatic end-neuroma with a new bioresorbable copolyester nerve capping device: a multicenter prospective cohort study.","volume":"91","author":"Power","year":"2023","journal-title":"Ann Plast Surg"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.hcl.2021.04.002","article-title":"Traditional neuroma management.","volume":"37","author":"Starr","year":"2021","journal-title":"Hand Clin"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/pmrj.12972","article-title":"Targeted muscle reinnervation and regenerative peripheral nerve interfaces for pain prophylaxis and treatment: a systematic review.","volume":"15","author":"Mauch","year":"2023","journal-title":"PM R"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1007\/s11999-014-3528-7","article-title":"Targeted muscle reinnervation: a novel approach to postamputation neuroma pain.","volume":"472","author":"Souza","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PRS.0000000000008153","article-title":"Targeted muscle reinnervation improves pain and ambulation outcomes in highly comorbid amputees.","volume":"148","author":"Chang","year":"2021","journal-title":"Plast Reconstr Surg"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/wound.2016.0717","article-title":"Targeted muscle reinnervation to improve pain, prosthetic tolerance, and bioprosthetic outcomes in the amputee.","volume":"6","author":"Bowen","year":"2017","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/SAP.0000000000003836","article-title":"Combined targeted muscle reinnervation with regenerative peripheral nerve interfaces decreases long-term narcotic use in amputees: a case control study.","volume":"92","author":"Wee","year":"2024","journal-title":"Ann Plast Surg"},{"key":"R21-20251215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bjps.2024.07.055","article-title":"Targeted muscle reinnervation at the time of amputation to prevent the development of neuropathic pain.","volume":"97","author":"Rasveld","year":"2024","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R22-20251215","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/SLA.0000000000003088","article-title":"Targeted muscle reinnervation treats neuroma and phantom pain in major limb amputees: a randomized clinical trial.","volume":"270","author":"Dumanian","year":"2019","journal-title":"Ann Surg"},{"key":"R23-20251215","doi-asserted-by":"crossref","first-page":"e2689","DOI":"10.1097\/GOX.0000000000002689","article-title":"Targeted muscle reinnervation combined with a vascularized pedicled regenerative peripheral nerve interface.","volume":"8","author":"Valerio","year":"2020","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R25-20251215","doi-asserted-by":"crossref","first-page":"114079","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives.","volume":"180","author":"Shi","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"R26-20251215","doi-asserted-by":"crossref","first-page":"1603752","DOI":"10.3389\/fcell.2025.1603752","article-title":"Pharmacologically targeting Schwann cells to improve regeneration following nerve damage.","volume":"13","author":"Alhamdi","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"R27-20251215","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1097\/j.pain.0000000000002202","article-title":"Prevalence of residual limb pain and symptomatic neuromas after lower extremity amputation: a systematic review and meta-analysis.","volume":"162","author":"List","year":"2021","journal-title":"Pain"},{"key":"R28-20251215","doi-asserted-by":"crossref","first-page":"651e","DOI":"10.1097\/PRS.0000000000007235","article-title":"Targeted muscle reinnervation as a solution for nerve pain.","volume":"146","author":"Lanier","year":"2020","journal-title":"Plast Reconstr Surg"},{"key":"R29-20251215","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.2009.116","article-title":"Targeted muscle reinnervation for real-time myoelectric control of multifunction artificial arms.","volume":"301","author":"Kuiken","year":"2009","journal-title":"JAMA"},{"key":"R30-20251215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/BTO.0000000000000194","article-title":"Targeted muscle reinnervation for the upper and lower extremity.","volume":"32","author":"Kuiken","year":"2017","journal-title":"Tech Orthop"},{"key":"R31-20251215","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.jvs.2020.04.060","article-title":"Targeted muscle reinnervation reduces pain and improves ambulation in patients undergoing below-knee amputation: a single-institution matched cohort study.","volume":"72","author":"Chang","year":"2020","journal-title":"J Vasc Surg"},{"key":"R32-20251215","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.2147\/JPR.S523451","article-title":"Clinically reducing\/eliminating chronic neuropathic pain by bridging peripheral nerve gaps with an autograft within a PRP-filled collagen tube.","volume":"18","author":"Kuffler","year":"2025","journal-title":"J Pain Res"},{"key":"R33-20251215","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.3389\/ebm.2025.10567","article-title":"Mechanisms for reducing\/eliminating chronic neuropathic pain with a focus on platelet-rich plasma.","volume":"250","author":"Kuffler","year":"2025","journal-title":"Exp Biol Med (Maywood)"},{"key":"R34-20251215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.GOX.0000799624.50102.7f","article-title":"Assessing the risk of perioperative complications after targeted muscle reinnervation and below knee amputation: a multi-institutional propensity score-matched analysis.","volume":"9","author":"Shammas","year":"2021","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R35-20251215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/SAP.0000000000001117","article-title":"Epineural sheath jacket as a new surgical technique for neuroma prevention in the rat sciatic nerve model.","volume":"79","author":"Siemionow","year":"2017","journal-title":"Ann Plast Surg"},{"key":"R36-20251215","first-page":"489","article-title":"Utilization of Silastic nerve caps for the treatment of amputation neuromas.","volume":"25","author":"Midenberg","year":"1986","journal-title":"J Foot Surg"},{"key":"R37-20251215","doi-asserted-by":"crossref","first-page":"e0200548","DOI":"10.1371\/journal.pone.0200548","article-title":"Time course of traumatic neuroma development.","volume":"13","author":"Oliveira","year":"2018","journal-title":"PLoS One"}],"container-title":["Plastic and Reconstructive Surgery - Global Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:00:53Z","timestamp":1765803653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/gox.0000000000007339","relation":{},"ISSN":["2169-7574"],"issn-type":[{"value":"2169-7574","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}